首页> 美国卫生研究院文献>NPJ Primary Care Respiratory Medicine >Should the diagnosis of COPD be based on a single spirometry test?
【2h】

Should the diagnosis of COPD be based on a single spirometry test?

机译:COPD的诊断是否应基于单个肺活量检查?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical guidelines indicate that a chronic obstructive pulmonary disease (COPD) diagnosis is made from a single spirometry test. However, long-term stability of diagnosis based on forced expiratory volume in 1 s over forced vital capacity (FEV1/FVC) ratio has not been reported. In primary care subjects at risk for COPD, we investigated shifts in diagnostic category (obstructedon-obstructed). The data were from symptomatic 40+ years (ex-)smokers referred for diagnostic spirometry, with three spirometry tests, each 12±2 months apart. The obstruction was based on post-bronchodilator FEV1/FVC < lower limit of normal (LLN) and <0.70 (fixed ratio). A total of 2,352 subjects (54% male, post-bronchodilator FEV1 76.5% predicted) were studied. By LLN definition, 32.2% were obstructed at baseline, but 32.2% of them were no longer obstructed at years 1 and/or 2. By fixed ratio, these figures were 46.6 and 23.8%, respectively. Overall, 14.3% of subjects changed diagnostic category by 1 year and 15.4% by 2 years when applying the LLN cut-off, and 15.1 and 14.6% by fixed ratio. Change from obstructed to non-obstructed was more likely for patients with higher body mass index (BMI) and baseline short-acting bronchodilator (SABA) users, and less likely for older subjects, those with lower FEV1% predicted, baseline inhaled steroid users, and current smokers or SABA users at year 1. Change from non-obstructed to obstructed was more likely for males, older subjects, current smokers and patients with lower baseline FEV1% predicted, and less likely for those with higher baseline BMI. Up to one-third of symptomatic (ex-)smokers with baseline obstruction on diagnostic spirometry had shifted to non-obstructed when routinely re-tested after 1 or 2 years. Given the implications for patients and health systems of a diagnosis of COPD, it should not be based on a single spirometry test.
机译:临床指南表明,通过单次肺活量测定测试即可诊断出慢性阻塞性肺疾病(COPD)。但是,尚未报告基于1 s内的呼气量超过强制肺活量(FEV1 / FVC)比的诊断的长期稳定性。在有COPD风险的初级保健对象中,我们调查了诊断类别的变化(阻塞/非阻塞)。数据来自有症状的40岁以上(前)吸烟者,他们被诊断为肺活量测定法,并进行了3次肺活量测定法测试,每次间隔12±2个月。阻塞的依据是支气管扩张剂后FEV1 / FVC <正常下限(LLN)和<0.70(固定比率)。共研究了2352名受试者(男性54%,支气管扩张剂后FEV1预测为76.5%)。根据LLN定义,基线时阻塞了32.2%,但是在第1年和/或第2年不再阻塞了32.2%。按固定比率,这些数字分别为46.6和23.8%。总体而言,应用LLN临界值时,有14.3%的受试者在1年内改变了诊断类别,在2年的时间内有15.4%改变了诊断类别,按固定比例改变了15.1和14.6%。对于体重指数(BMI)和基线短效支气管扩张剂(SABA)使用者较高的患者,由阻塞型变为非阻塞型的可能性更大;而对于FEV1%较低的基线吸入类固醇使用者,老年受试者的可能性较小,以及第1年时的当前吸烟者或SABA使用者。男性,年龄较大的受试者,当前吸烟者和基线FEV1%较低的患者更有可能从无阻塞变为阻塞,而基线BMI较高的患者则较不可能。在经过1或2年的例行常规检查后,诊断性肺活量测定法中基线阻塞的有症状(前)吸烟者中,多达三分之一已转移为无阻塞。考虑到COPD诊断对患者和健康系统的影响,因此不应基于单个肺活量测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号